Loading data
JHXNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 4.84 bn USD | 3.88 bn USD | 3.94 bn USD | 3.78 bn USD | 3.61 bn USD |
| Cost of revenue | 3.11 bn USD | 2.37 bn USD | 2.35 bn USD | 2.47 bn USD | 2.3 bn USD |
| Gross profit | 1.73 bn USD | 1.51 bn USD | 1.59 bn USD | 1.31 bn USD | 1.31 bn USD |
| Research and development expense | 60.7 m USD | 48.5 m USD | 47 m USD | 39.6 m USD | 38 m USD |
| Selling, general and administrative expense | 946.4 m USD | 596.2 m USD | 602.2 m USD | 494 m USD | 461.2 m USD |
| Operating profit | 447.6 m USD | 655.9 m USD | 767.4 m USD | 741.4 m USD | 682.6 m USD |
| Profit before tax | 206.7 m USD | 645.4 m USD | 754.8 m USD | 723.5 m USD | 643.1 m USD |
| Income tax expense | 102.7 m USD | 221.4 m USD | 244.6 m USD | 211.5 m USD | 184 m USD |
| Net income (reported basis) | 104 m USD | 424 m USD | 510.2 m USD | 512 m USD | 459.1 m USD |
| Basic earnings per share | 0.19 USD/share | 0.98 USD/share | 1.16 USD/share | 1.15 USD/share | 1.03 USD/share |
| Diluted earnings per share | 0.19 USD/share | 0.98 USD/share | 1.16 USD/share | 1.15 USD/share | 1.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.